US OptionsDetailed Quotes

VYGR241220C7500

Watchlist

0.10
-0.05-33.33%

15min DelayClose Dec 3 16:00 ET

0.10High0.10Low

Voyager Therapeutics Stock Discussion

BeeDeeVee712

Nov 29 14:43

$Voyager Therapeutics (VYGR.US)$ 👀 👀 👀

Tonyco

Nov 17 09:43

$Voyager Therapeutics (VYGR.US)$
Very oversold, less than 1% profitable positions, undervalued by all except p/e which is still under market avg.

BeeDeeVee712

Oct 4 15:47

$Voyager Therapeutics (VYGR.US)$ I got in on this around April of this year for around $6.30-6.40 and have been holding it just waiting for it to completely crash. I'm not sure exactly what caused the uptick today but I do know I'm extremely tempted to sell it all off and take the smaller profits (actually I'm definitely going to sell some for that), but I'm not sure, I think this company still has potential long-term, I was just blown away by how stagnant it had been for months. Anyone else have...

Tonyco

Sep 19 12:29

$Voyager Therapeutics (VYGR.US)$
This was over $10 recently, and earnings were great, except Wall St was scared of recession at the time. I'm guessing once they are satisfied, this will go back up

Trytosaveabit

Sep 5 07:04

News

$Voyager Therapeutics (VYGR.US)$ Press Release: Voyager Enters Into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Dow Jones· 2 mins ago
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royalties

Jaguar8

Sep 5 07:01

NEWS

$Voyager Therapeutics (VYGR.US)$
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Voyager Therapeutics (Nasdaq: VYGR) has announced a new license agreement with Novartis AG (NYSE: NVS) for a novel capsid from Voyager's TRACER™ capsid discovery platform. The capsid will be used in a gene therapy program targeting an undisclosed rare neurologic disease. This agreement expands Voyager's partnered portfolio of TRACER-enabl...

Tonyco

Aug 30 01:40

$Voyager Therapeutics (VYGR.US)$
Looks like 6 holds the big buy but we shall see. Don't expect it to get much lower.

BeeDeeVee712

Aug 22 19:04

$Voyager Therapeutics (VYGR.US)$ Man, I've been holding this for awhile (since late Q1 this year) and it just can't ever seem to get that boost and then that second boost that I was really expecting to come by the end of summer. I guess there's still time and I'm only in @ $7.15 or so, so it could definitely be worse. I'm still expecting this to take off at some point.

BeeDeeVee712

Jul 11 15:36

$Voyager Therapeutics (VYGR.US)$ Finally some movement on this one I bought in at just under $8 a few months ago and have just been holding while this has seemly remained stagnant. Hopefully today's movement is a nice sign of what is to come 😁.

Trytosaveabit

May 16 06:18

Update

$Voyager Therapeutics (VYGR.US)$ Benzinga· 2 mins ago
Voyager Therapeutics Says First Participants Dosed In Single Ascending Dose Trial of VY-TAU01 For Treatment Of Alzheimer's Disease

No comment yet